Higher IC50 levels were detected in HNSCC cells treated with prolonged hyperglycemia suggesting that high glucose inputs could protect HNSCC cells from cisplatin-mediated cytotoxicity (Figure 1E), probably via significant increased expression of the drug-resistant mediator ABCG2 mRNA (Figure 1F). Here, ABCG2 is linked to head and neck squamous cell carcinoma.